SEC Form 4 · accession 0001104659-26-076477
COGNITION THERAPEUTICS INC · CGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack A. Khattar
Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 5:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001455365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 17, 2026 | A | 25,000 | $0.00 | A | 73,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.